Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols
Authors:
- Bastian FrehlandBFBastian Frehland
- Dirk SchepmannDSDirk Schepmann
- Kai-Uwe SchmidtkeKSKai-Uwe Schmidtke
- Thomas WincklerTWThomas Winckler
- Bernhard WünschBWBernhard Wünsch
- 1 November 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (22) , 8005-8015
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptorsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Design, Synthesis, and Biological Evaluation of 3‐Benzazepin‐1‐ols as NR2B‐Selective NMDA Receptor AntagonistsChemMedChem, 2010
- Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological ProfileChemMedChem, 2008
- NMDA receptor subunits: function and pharmacologyCurrent Opinion in Pharmacology, 2007
- Asymmetric Synthesis of 1‐Substituted Tetrahydro‐3‐benzazepines as NMDA Receptor AntagonistsEuropean Journal of Organic Chemistry, 2007
- Ionotropic and metabotropic glutamate receptor structure and pharmacologyPsychopharmacology, 2005
- Slow fluorescent indicators of membrane potential: a survey of different approaches to probe response analysisJournal of Photochemistry and Photobiology B: Biology, 1996
- Continuous subcutaneous administration of the N -methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgiaPain, 1995
- The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humansPain, 1992
- Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mousePsychopharmacology, 1968